VERACYTE, INC.·4

Dec 8, 5:18 PM ET

Kennedy Giulia C 4

4 · VERACYTE, INC. · Filed Dec 8, 2022

Insider Transaction Report

Form 4
Period: 2022-12-06
Kennedy Giulia C
Chief Scientific & Med Officer
Transactions
  • Sale

    Common Stock

    2022-12-06$27.03/sh1,023$27,65265,970 total
Footnotes (1)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 14, 2022.

Documents

1 file
  • 4
    wf-form4_167053791573091.xmlPrimary

    FORM 4